XPONANCE LLC

Position in PCVX — Vaxcyte, Inc.

CIK 1637541 PHILADELPHIA, PA

Position in PCVX

as of Jun 30, 2026 · filed Aug 10, 2026 Compact

Position Value

$758,596

+$96,259 QoQ

Shares Held

13,050

+14.5% QoQ

Ownership

0.009%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

#175

of 329 holders

Holding Since

Jun 2023

13 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

XPONANCE LLC holds $117,846,021 across 121 Biotechnology names. PCVX ranks #27 (0.6% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	VRTX	Vertex Pharmaceuticals Inc / Ma	45,980	$22,839,645
2	REGN	Regeneron Pharmaceuticals, Inc.	18,063	$11,263,003
3	ALNY	Alnylam Pharmaceuticals, Inc.	30,242	$9,103,749
4	RVMD	Revolution Medicines, Inc.	40,460	$7,577,348
5	INSM	INSMED Inc	48,273	$5,146,867
6	INCY	Incyte Corp	29,027	$3,290,500
7	RPRX	Royalty Pharma plc	55,752	$3,126,014
8	MRNA	Moderna, Inc.	39,368	$2,756,941

13 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$758,596	13,050	+14.5%	Shares	Sole	2026-08-10
2026-03-31	$662,337	11,398	+25.5%	Shares	Sole	2026-05-13
2025-12-31	$418,951	9,080	+0.8%	Shares	Sole	2026-02-12
2025-09-30	$324,576	9,011	-7.3%	Shares	Sole	2025-11-12
2025-06-30	$315,964	9,719	+4.3%	Shares	Sole	2025-08-14
2025-03-31	$351,923	9,320	+4.7%	Shares	Sole	2025-05-01
2024-12-31	$728,963	8,905	+13.4%	Shares	Sole	2025-02-11
2024-09-30	$897,362	7,853	+13.6%	Shares	Sole	2024-11-12
2024-06-30	$522,076	6,914	+7.2%	Shares	Sole	2024-08-14
2024-03-31	$440,531	6,449	+13.7%	Shares	Sole	2024-05-13
2023-12-31	$356,201	5,672	+3.0%	Shares	Sole	2024-01-31
2023-09-30	$280,848	5,509	+1.8%	Shares	Sole	2023-10-24
2023-06-30	$270,275	5,412	—	Shares	Sole	2023-07-14
No filing history on record for this holder in this stock.